Genzyme Accuses Shire Of Making False Bone Drug Claims

Law360, New York (July 30, 2012, 7:32 PM EDT) -- Sanofi SA subsidiary Genzyme Corp. filed a lawsuit Monday in Massachusetts accusing rival Shire Human Genetic Therapies Inc. of misleading consumers by issuing a press release touting purported clinical evidence that its bone disease drug is superior to Genzyme’s market-leading Cerezyme.

Genzyme is fighting back against a June 28 Shire release that purported to describe new data from a head-to-head clinical trial showing Shire’s VPRIV drug for the treatment of Gaucher-related bone disease improved lumbar spine density while Genzyme’s Cerezyme did not, saying the conclusions come...
To view the full article, register now.